Comprehensive analysis of genetic alterations in NSCLC has identified key signaling pathways and genes, such as EGFR, TP53, KRAS, PIK3CA, STK11, BRAF, ERBB2, MET, and PARK2 [34–37]. The gene discussed is BRAF; the disease is non-small cell lung carcinoma.